Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial.

Rajji TK, Baksh SN, Shade DM, Ismail Z, Burhan AM, Okhravi HR, Padala PR, Rosenberg PB, Schneider LS, Porsteinsson AP, Lyketsos CG, S-CitAD Research Group

Open source

DOI: 10.1038/s41591-025-03569-y
Published: 2025 May
Container: Nature medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-025-03569-y,
  title = {Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial.},
  author = {Rajji TK and Baksh SN and Shade DM and Ismail Z and Burhan AM and Okhravi HR and Padala PR and Rosenberg PB and Schneider LS and Porsteinsson AP and Lyketsos CG and S-CitAD Research Group},
  year = {2025},
  journal = {Nature medicine},
  doi = {10.1038/s41591-025-03569-y},
  url = {https://doi.org/10.1038/s41591-025-03569-y}
}

RIS

TY  - JOUR
TI  - Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial.
AU  - Rajji TK
AU  - Baksh SN
AU  - Shade DM
AU  - Ismail Z
AU  - Burhan AM
AU  - Okhravi HR
AU  - Padala PR
AU  - Rosenberg PB
AU  - Schneider LS
AU  - Porsteinsson AP
AU  - Lyketsos CG
AU  - S-CitAD Research Group
PY  - 2025
JO  - Nature medicine
DO  - 10.1038/s41591-025-03569-y
UR  - https://doi.org/10.1038/s41591-025-03569-y
ER  -

APA

TK, R., SN, B., DM, S., Z, I., AM, B., HR, O., PR, P., PB, R., LS, S., AP, P., CG, L., & Group, S. R. (2025). Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial.. Nature medicine. https://doi.org/10.1038/s41591-025-03569-y

Source records

pubmed · retrieved 2026-09-26T03:52:51.413Z